Profile
Noa Therapeutics is a preclinical biotech company pioneering the development of homeostatic modulating small molecules, targeting barrier resolution, to effectively modify pathogenic drivers of inflammatory diseases. Adopting a systems biology and computer-assisted discovery approach, Noa is establishing a novel small molecule platform for the tailored treatment of immune diseases involving barrier dysfunction to address unmet needs in over $100B of inflammatory disease markets.
Website
noatherapeutics.comContact
-
Carla Spina, Chief Executive Officer and Co-FounderTel: +1 647-857-1142Email: carlaspina@noathera.com
-
-
-
-
-
Event details
Name: Ontario at BIO 2025
Date: June 16 - 19, 2025
Event contact
Patricia Cosgrove
Senior International Market Consultant
U.S.A. & Europe
Tel: +1 647-293-6306
Email: patricia.cosgrove@ontario.ca